Both in Lab Analytical Instruments
908 Devices vs Pacific Biosciences of California
Over the past year MASS returned +45.4% and PACB returned +46.4%; their daily moves had a correlation of 0.45.
MASS +45.4% PACB +46.4%Growth of $1, one year, split-adjusted
| Metric | MASS | PACB |
|---|---|---|
| Price | $11.85 | $1.83 |
| Market cap | $489.8M | $568.8M |
| Today | +1.63% | +7.02% |
| 1 month | +10.4% | +30.7% |
| 6 months | +106.1% | +45.2% |
| Year to date | +125.7% | −2.1% |
| 1 year | +47.9% | +51.2% |
| Revenue growth (YoY) | +23.3% | −1.9% |
| Gross margin | 51.9% | 32.4% |
| Net margin | −74.0% | −114.7% |
| P/E (TTM) | — | — |
| Price / sales | 8.1× | 3.6× |
| Net cash | $101.5M | -$407.5M |
| Dividend yield | — | — |
| Volatility (60d) | 58.4% | 83.2% |
| Short % of float | 9.8% | 19.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).